Breast cancer risk with hormone replacement after risk-reducing Salpingo-oophorectomy in BRCA mutation carriers: does it abrogate the benefit?

Barlin, Joyce

193 - Poster Session A
Breast cancer risk with hormone replacement after risk-reducing Salpingo-oophorectomy in BRCA mutation carriers: does it abrogate the benefit?

Saturday, March 22, 2014: 3:05 AM

West Exhibit Hall (Tampa Convention Center)

J. N. Barlin¹, A. Arnold¹, S. Mobley¹, E. Otegbeye¹, Z. K. Stadler¹, M. E. Robson¹, K. Offit¹, R. R. Barakat² and N. D. Kauff²
¹Memorial Sloan-Kettering Cancer Center, New York, NY, ²Memorial Sloan Kettering Cancer Center, New York, NY

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

193 - Poster Session A
Breast cancer risk with hormone replacement after risk-reducing Salpingo-oophorectomy in BRCA mutation carriers: does it abrogate the benefit?

193 - Poster Session A Breast cancer risk with hormone replacement after risk-reducing Salpingo-oophorectomy in BRCA mutation carriers: does it abrogate the benefit?

193 - Poster Session A
Breast cancer risk with hormone replacement after risk-reducing Salpingo-oophorectomy in BRCA mutation carriers: does it abrogate the benefit?